Daniel Anderson

Professor

Department
Department of Chemical Engineering
Technology Areas
Biotechnology: DNA & RNA Editing, Biomedical Devices & Systems, Sensors & Monitoring, Synthetic Biology / Chemicals & Materials: Catalysis & Synthesis, Nanotechnology & Nanomaterials, Polymers, Composites / Drug Discovery and Research Tools: Genomics & Proteomics, Cell Interrogation, Cell Lines & Organoids, Cell Culture / Therapeutics: Nucleic Acids, Small Molecules, Cell Based Therapy, Vaccines, Proteins & Antibodies, Regenerative Medicine / Drug Delivery: Microparticles & Nanoparticles, Vectors & Virus like Particles / Artificial Intelligence (AI) and Machine Learning (ML) / Sensing & Imaging: Imaging, Chemical & Radiation Sensing / Energy & Distribution: Electrochemical Devices / Biomaterials & Bioelectronics: Medical Device Coatings, Health Monitoring / Computer Science: Bioinformatics / Diagnostics: Assays

Pioneering smart materials for advancements in medical devices, drug delivery, and gene therapy, with a prolific publication record and significant impact across multiple disciplines.

Background and Experience

Daniel G. Anderson is a leading researcher in the fields of nanotherapeutics and biomaterials and has pioneered the development of smart materials. In addition to the Koch Institute, he holds appointments in MIT’s Department of Chemical Engineering, Institute for Medical Engineering and Science, and Harvard-MIT Division of Health Science and Technology. Anderson received a BA in mathematics and biology from the University of California at Santa Cruz and a PhD in molecular genetics from the University of California at Davis. Anderson’s work has led to advances in a range of areas, including medical devices, cell therapy, drug delivery, gene therapy and material science, and has resulted in the publication of more than 500 papers, patents, and patent applications. He is the recipient of the 2023 Wilhelm Exner Medal.

Technologies

Polymer Brush-Poly(glycoamidoamine)-Lipids (PGAL) and Uses Thereof

Technology / Case number: #15942
Yizhou Dong / Joseph Dorkin / Robert Langer / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery
Impact Areas: Healthy Living
License

Method for High Efficiency in Vivo Gene Editing

Technology / Case number: #17117H
Wen Xue / Joseph Dorkin / Hao Yin / Tyler Jacks / Daniel Anderson
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Amino-Amidine Based Polymers for Drug Delivery

Technology / Case number: #14057Q
Kathryn Whitehead / Arturo Vegas / Joseph Dorkin / Robert Langer / Daniel Anderson
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Methods for Cell Separation and Cytometry Based on Directed Cell Rolling on Patterned Substrates

Technology / Case number: #12899
Jeffrey Michael Karp / Seungpyo Hong / Rohit N Karnik / Ying Mei / Suman Bose / Robert Langer / Daniel Anderson
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Thiol-yne Mediated Synthesis of Multi-Tailed Lipids for siRNA Delivery

Technology / Case number: #15846
Kevin Love / Akinleye Alabi / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Injectable Hydrogel and Uses Thereof

Technology / Case number: #16662J
Yizhou Dong / Benjamin Tang / Kun Xue / Matthew Webber / Omid Veiseh / Weiheng Wang / Eric Appel / Robert Langer / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery
License

Zwitterionic Polymer Functionalized Lipid Nanoparticles for Delivery of mRNA

Technology / Case number: #24662
Robert Langer / Allen Jiang / Sushil Lathwal / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Glucose- Responsive Microgels for Closed Loop Insulin Delivery

Technology / Case number: #15057J
Zhen Gu / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials
License

Ionizable Lipid OF-02 and its Use in mRNA Delivery

Technology / Case number: #17733
Joseph Dorkin / Owen Fenton / Kevin Kauffman / Rebecca McClellan / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery
License

Oligomeric Conjugates for siRNA Delivery and Glucose-Responsive Insulins

Technology / Case number: #15977J
Arturo Vegas / Rosemary Kanasty / Robert Langer / Daniel Anderson
Technology Areas: Diagnostics / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.